LSTA compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

LSTALisata Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

LSTALisata Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LSTALisata Therapeutics, Inc.

1.02▼−4.11%· post 1.02· delayed

Mkt cap$9.6MRevenue$100,000Q4 FY25Revenue—

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,362.00· delayed

After hoursNov 5 '26delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

After hoursNov 5 '26delayed

LSTALisata Therapeutics, Inc.

LLYELI Lilly & Co

1.02▼−4.11%post 1.02delayed

Price

1,371.32▼−3.29%post 1,362.00delayed

$9.6M

Mkt cap

$1.3T

Q4 FY25$100,000

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

LSTA1.02▼−4.11%vsLLY1,371.32▼−3.29%After hoursNov 5 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LSTA 7

—Sanford Burnham Prebys Medical Discovery Instituteunlistedsupplier

—Australasian Gastrointestinal Clinical Trials Group (AGITG)unlistedsupplier

—University of Sydneyunlistedsupplier

—Catalentunlistedsupplier

3 more · LSTA chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›